Depression in multiple sclerosis: a review

Cited by (723)

Items 301–400 of 723

1. BICAMS in the Argentine population: Relationship with clinical and sociodemographic variables
   Sandra Vanotti, Alan Smerbeck, María Bárbara Eizaguirre, Maria L. Saladino, Ralph R. H. Benedict, Fernando Cáceres · 2017 · Applied Neuropsychology Adult
2. Living with multiple sclerosis: A Jordanian perspective
   Alham Al‐Sharman, Hanan W. Khalil, Mohammad S. Nazzal, Nihaya Al‐Sheyab, Alia A. Alghwiri, Khalid El‐Salem, Mais AlDughmi · 2018 · Physiotherapy Research International
3. Heterogeneous depression trajectories in multiple sclerosis patients
   Douglas David Gunzler, Nathan J. Morris, Adam T. Perzynski, Daniel Ontaneda, Farren B. S. Briggs, Deborah M. Miller, Robert A. Bermel · 2016 · Multiple Sclerosis and Related Disorders
4. Cognitive and neuropsychiatric disorders among MS patients from Latin America
   Sandra Vanotti, Fernando Cáceres · 2017 · Multiple Sclerosis Journal - Experimental Translational and Clinical
5. Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management
   Dean M. Wingerchuk · 2006 · Expert Review of Neurotherapeutics
6. The payer’s perspective: What is the burden of MS and how should the patient’s perspective be integrated in health technology assessment conducted for taking decisions on access to care and treatment?
   Ralf Gold, Mondher Toumi, Bianca Meesen, Emer Fogarty · 2016 · Multiple Sclerosis Journal
7. Polish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS battery): correlation of cognitive impairment with mood disorders and fatigue
   Ewa Betscher, Wojciech Guenter, Dawn Wendy Langdon, Robert Bonek · 2020 · Neurologia i Neurochirurgia Polska
8. Massage therapy as a complementary and alternative approach for people with multiple sclerosis: a systematic review
   Zakieh Heidari, Shahnaz Shahrbanian, Chungyi Chiu · 2021 · Disability and Rehabilitation
9. The emotional disorders associated with multiple sclerosis
   Simona Raimo, Gabriella Santangelo, Luigi Trojano · 2021 · Handbook of clinical neurology
10. Stress-stimulated volitional coping competencies and depression in multiple sclerosis
    J. Nielsen-Prohl, Jochen Saliger, V. Güldenberg, G. Breier, H. Karbe · 2012 · Journal of Psychosomatic Research
11. The relationships between apathy and executive dysfunction in multiple sclerosis.
    Simona Raimo, Luigi Trojano, Daniele L.A. Spitaleri, Vittorio Petretta, Dario Grossi, Gabriella Santangelo · 2016 · Neuropsychology
12. Multiple Sclerosis and Behavior
    James B. Pinkston, Anita S. Kablinger, Nadejda Alekseeva · 2007 · International review of neurobiology
13. Utilization Patterns of Oral Disease-Modifying Drugs in Commercially Insured Patients with Multiple Sclerosis
    Rishi J. Desai, Mufaddal Mahesri, Joshua J. Gagne, Eimir Hurley, Angela Tong, Tanuja Chitnis, Sarah L. Minden, Claire M. Spettell, Olga S. Matlin, William H. Shrank et al. · 2018 · Journal of Managed Care & Specialty Pharmacy
14. Personality traits of patients with multiple sclerosis and their correlation with anxiety and depression levels: A cross‐sectional case–control study
    Amirali Ghahremani, Sahar Mosa Farkhani, Mahsa Baniasadi, Seyed Kaveh Hojjat, Hasan Namdar Ahmadabad, Davoud Salarbashi, Sepideh Elyasi, Najmeh Davoodian · 2022 · Brain and Behavior
15. The Use of Antidepressant Medication before and after the Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Cohort Study
    Federica Edith Pisa, Giancarlo Logroscino, Anica Casetta, Laura Cecotti, Lorenzo Verriello, Alessio Bratina, Arianna Sartori, Lucio Lazzarino de Lorenzo, Roberto Eleopra, Fabio Barbone · 2015 · Neuroepidemiology
16. Factors affecting dignity of patients with multiple sclerosis
    Simin Sharifi, Fariba Borhani, Abbas Abbaszadeh · 2016 · Scandinavian Journal of Caring Sciences
17. A psychoeducation program for stress management and psychosocial problems in multiple sclerosis
    Hilal Seki Öz, Fatma Öz · 2020 · Nigerian Journal of Clinical Practice
18. Persistent interferon‐β‐1b‐induced psychosis in a patient with multiple sclerosis
    Giovanni Manfredi, Georgios Demetrios Kotzalidis, Gabriele Sani, Alexia Emilia Koukopoulos, Valeria Savoja, Simone Lazanio, Nicoletta Girardi, Roberto Tatarelli · 2010 · Psychiatry and Clinical Neurosciences
19. Evaluating Neurocognitive Deficits in Patients With Multiple Sclerosis Via a Brief Neuropsychological Approach
    Andrew S. Davis, Ronald N. Williams, Ajay S. Gupta, W. Holmes Finch, CHRISTOPHER C. RANDOLPH · 2015 · Applied Neuropsychology Adult
20. Increase in Interleukin-6 Levels Is Related to Depressive Phenomena in the Acute (Relapsing) Phase of Multiple Sclerosis
    Effrosyni Koutsouraki, Eleni Hatzifilippou, Dimitrios Michmizos, Christos Cotsavasiloglou, Vassiliki Costa, Stavros Balogiannis · 2011 · Journal of Neuropsychiatry
21. Improved Detection and Evaluation of Depression in Patients with Chronic Kidney Disease: Validity and Reliability of Screening (PHQ-2) and Diagnostic (BDI-FS-Fr) Tests of Depression in Chronic Kidney Disease
    Muaweah Ahmad Alsaleh, Ludivine Videloup, Thierry Lobbedez, Joëlle Lebreuilly, Rémy Morello, Angélique Thuillier Lecouf · 2019 · Kidney Diseases
22. The relation between goal adjustment, goal disturbance, and mental well-being among persons with multiple sclerosis
    Stefaan Van Damme, Sara Kindt, Geert Crombez, Liesbet Goubert, Jan Debruyne · 2019 · Psychology and Health
23. rTMS ameliorates depression/anxiety-like behaviors in experimental autoimmune encephalitis by inhibiting neurotoxic reactive astrocytes
    Chao Yu, Yiwen Ruan, Xiaobo Sun, Chen Chen, Ting Shen, Chunxin Liu, Wei Qiu, Zhengqi Lu, Sun On Chan, Liqing Wang · 2023 · Journal of Affective Disorders
24. Event related potential and response time give evidence for a physiological reserve in cognitive functioning in relapsing–remitting multiple sclerosis
    Mathias Sundgren, Åke Wåhlin, Liselotte Maurex, Tom Brismar · 2015 · Journal of the Neurological Sciences
25. Multiple sclerosis and depression
    Vicki Matthews · 2011 · British Journal of Wellbeing
26. Relationship Between Disease-Modifying Therapy and Depression in Multiple Sclerosis
    Stephen S. Kirzinger, Jason P. Jones, Angela Siegwald, Andrew Bryce Crush · 2013 · International Journal of MS Care
27. Hypnotherapy for disability-related pain: A meta-analysis
    Emma Bowker, Diana Dorstyn · 2014 · Journal of Health Psychology
28. Changes in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ER
    Elizabeth Westerlund Triche, Jennifer A. Ruiz, Kayla M. Olson, Albert Lo · 2016 · Clinical Neuropharmacology
29. The clinical correlates of participation levels in people with multiple sclerosis
    Eman Allataifeh, Hanan W. Khalil, Khader A. Almhdawi, Alham Al‐Sharman, Ziad M. Hawamdeh, Khalid El‐Salem, Gonca Bumın · 2020 · Neurorehabilitation
30. Serum and CSF Biomarkers Predict Active Early Cognitive Decline Rather Than Established Cognitive Impairment at the Moment of RRMS Diagnosis
    Vlad Eugen Tiu, Bogdan Ovidiu Popescu, Iulian Ion Enache, Cristina Tiu, Elena Terecoasă, Cristina Panea · 2022 · Diagnostics
31. Fear of Disease Progression in Patients with Multiple Sclerosis: Associations of Anxiety, Depression, Quality of Life, Social Support and Knowledge
    2014 · Journal of Clinical Research & Governance
32. Cognitive dysfunction 24–31 years after isolated optic neuritis
    Petra Nilsson, Ia Rorsman, EM Larsson, Bo G Norrving, Magnhild Sandberg‐Wollheim · 2008 · Multiple Sclerosis Journal
33. Determinants of low bone mineral density in people with multiple sclerosis: Role of physical activity
    Brice Thomas Cleland, Paula E. Papanek, Benjamin A. Ingraham, April L. Harkins, Mauricio Garnier‐Villarreal, Douglas A. Woo, Mary Ellen Csuka, Alexander V. Ng · 2019 · Multiple Sclerosis and Related Disorders
34. Behavior Change Techniques in Physical Activity Interventions for Multiple Sclerosis
    Stephanie L. Silveira, Trinh L. T. Huynh, Ariel L. Kidwell-Chandler, Dena Sadeghi Bahmani, Robert W. Motl · 2021 · Archives of Physical Medicine and Rehabilitation
35. MSLife
    Gabriel Guo, Hanbin Zhang, Liuyi Yao, Huining Li, Chenhan Xu, Zhengxiong Li, Wenyao Xu · 2021 · Proceedings of the ACM on Interactive Mobile Wearable and Ubiquitous Technologies
36. Anxiety, depression and impaired health-related quality of life are therapeutic challenges in patients with multiple sclerosis
    D. Michalski, S. Liebig, Eva Thomae, S. Singer, A. Hinz, F. T. Bergh · 2010 · Mental Illness
37. Profile of depression, experienced distress and capacity for coping with stress in multiple sclerosis patients—A different perspective
    Ana Ožura, Saša Šega · 2013 · Clinical Neurology and Neurosurgery
38. DEPRESSION IN NEUROLOGICAL PRACTICE
    Dmitry V. Romanov, D. S. Petelin, Beatrice A. Volel · 2018 · Meditsinskiy sovet = Medical Council
39. Psychiatric aspects of neurological disease
    María A. Ron · 2012
40. Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US
    Michele Jara, Barker, Herbert R. Henney · 2013 · Neuropsychiatric Disease and Treatment
41. Evaluation of a brief community‐based mindfulness intervention for people with multiple sclerosis: A pilot study
    Elizabeth Spitzer, Kenneth Ian Pakenham · 2016 · Clinical Psychologist
42. Computerized Cognitive Behavioral Therapy for Treatment of Depression in Multiple Sclerosis: A Narrative Review of Current Findings and Future Directions.
    Adrianna M. Ratajska, Jonathan Zurawski, B. Healy, B. Glanz · 2019 · International Journal of MS Care
43. Effects of enhanced environment and induced depression on cuprizone mouse model of demyelination
    Ayman Saber Mohamed, Ghada Al‐Kafaji, Amal Almahroos, Zahra Majid Al-Mosawi, Hawra Faisal Alalwan, Reem Abdulla, Fajer Alammadi, Ahmed Almubarak, Ahmed Al-Mahrezi, Amer Kamal · 2019 · Experimental and Therapeutic Medicine
44. Comorbidity effect on processing speed test and MRI measures in multiple sclerosis patients.
    Justin R. Abbatemarco, D. Ontaneda, Kunio Nakamura, S. Husak, Zhini Wang, Ebtesam Alshehri, R. Bermel, Devon S. Conway · 2020 · Multiple Sclerosis and Related Disorders
45. Survival after acute episodes of immune-mediated thrombotic thrombocytopenic purpura (iTTP) – cognitive functioning and health-related quality of life impact: a descriptive cross-sectional survey of adults living with iTTP in the United Kingdom
    Steve Holmes, Lauren Podger, Catherine J. Bottomley, Ewelina Rzepa, Karen Bailey, Fleur Chandler · 2021 · Hematology
46. Psychological impacts of COVID-19 pandemic on individuals living with multiple sclerosis: A rapid systematic review
    Amin Zarghami, Mohammad Akhtar Hussain, Julie A. Campbell, Chigozie Ezegbe, Ingrid A.F. van der Mei, Bruce V. Taylor, Suzi B. Claflin · 2022 · Multiple Sclerosis and Related Disorders
47. Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry
    Marta Bellofatto, Alessandro Bertini, Irene Tramacere, Fiore Manganelli, Gian Maria Fabrizi, Angelo E. Schenone, Lucio Santoro, Tiziana Cavallaro, Marina Grandis, Stefano Carlo Previtali et al. · 2022 · Journal of Neurology
48. Decreased hydrocortisone sensitivity of T cell function in multiple sclerosis-associated major depression
    Anja Fischer, Christian Otte, Thorsten Krieger, Robert A. Nicholls, Schulamith Krüger, Kristin J. Ziegler, Karl‐Heinz Schulz, Christoph Heesen, Stefan Michael Gold · 2012 · Psychoneuroendocrinology
49. Posttraumatic stress disorder symptoms in individuals with multiple sclerosis.
    Alyssa Counsell, Heather D. Hadjistavropoulos, Melissa D. Kehler, Gordon J. G. Asmundson · 2012 · Psychological Trauma Theory Research Practice and Policy
50. Brain structural changes in patients in the early stages of multiple sclerosis with depression
    Juan Ignacio Rojas, Francisco Sánchez, Liliana Patrucco, Jimena Míguez, Cristina Hilda Besada, Edgardo Cristiano · 2017 · Neurological Research
51. Diagnosis of depression in multiple sclerosis is predicted by frontal–parietal white matter tract disruption
    Kira Ashton, Tom A. Fuchs, Devon Oship, Robert Zivadinov, Dejan Jakimovski, Niels Bergsland, Deepa Preeti Ramasamy, Caila B. Vaughn, Bianca Weinstock‐Guttman, Ralph H. B. Benedict et al. · 2020 · Journal of Neurology
52. Patterns and Outcomes of Complementary and Alternative Medicine Use Among Adult Patients With Multiple Sclerosis
    Muhannad A Alnahdi, Abdullah K Alsulayhim, Ahmed H Bin Salem, Emad Masuadi, Yaser M. Al Malik · 2020 · Cureus
53. Impact of Armodafinil on Cognition in Multiple Sclerosis
    Jared M. Bruce, Laura M. Hancock, Brandon L. Roberg, Amberly Brown, Erik Henkelman, SHARON G. LYNCH · 2012 · Cognitive and Behavioral Neurology
54. The relation between the symbol digit modalities test, fatigue, depression, and anxiety symptoms in a Belgian MS cohort
    Serena Borrelli, J. Pereira Lima, Bernard Dachy · 2022 · Acta Neurologica Belgica
55. Relationship Between Global Cognitive Decline and Depressive Symptoms in Multiple Sclerosis
    Fiona H. Barwick, Peter A. Arnett · 2011 · The Clinical Neuropsychologist
56. Dépression et sclérose en plaques
    Christine Lebrun‐Frénay, Mikaël Cohen · 2009 · Revue Neurologique
57. The symptomatic management of multiple sclerosis
    Randall T. Schapiro · 2009 · Annals of Indian Academy of Neurology
58. The prevalence of depression and anxiety among Iranian people with multiple sclerosis: A systematic review and meta-analysis.
    Arman Shafiee, Hedieh Soltani, Mohammad Mobin Teymouri Athar, Kyana Jafarabady, Parham Mardi · 2023 · Multiple Sclerosis and Related Disorders
59. Autoimmune demyelination alters hypothalamic transcriptome and endocrine function
    Jonathan Jacob Carver, Kristy M. Lau, Alexandra E. Puckett, Alessandro Didonna · 2024 · Journal of Neuroinflammation
60. The importance of quality-of-life assessment in the management of patients with multiple sclerosis. Recommendations from the Middle East MS Advisory Group
    Abdel‐Rahman Al Tahan, Mohammed Aljumah, Saeed M Bohlega, Suhail N Al-Shammari, Isa Ahmed Alsharoqi, Maurice P Dahdaleh, Hassan M. Hosny, Bassem Yamout · 2011 · Neurosciences
61. The mediating role of processing speed in the relationship between depressive symptoms and cognitive function in multiple sclerosis
    Mervin Blair, Sascha Gill, Iris Gutmanis, Kathy Smolewska, Erin M. Warriner, Sarah Anne Morrow · 2016 · Journal of Clinical and Experimental Neuropsychology
62. Oculomotor fatigue and neuropsychological assessments mirror multiple sclerosis fatigue
    Wolfgang H. Zangemeister, Christof Heesen, Dorit Röhr, Stefan Michael Gold · 2020 · Journal of Eye Movement Research
63. Immune receptor toll-like receptor 4 contributes to stress-induced affective responses in a sex-specific manner
    Cana B. Quave, Steven J. Nieto, Colin N. Haile, Therese A. Kosten · 2021 · Brain Behavior & Immunity - Health
64. Depressive Disorders
    2022 · American Psychiatric Association Publishing eBooks
65. Reasons for discontinuation of subcutaneous interferon β-1a three times a week among patients with multiple sclerosis: a real-world cohort study
    Meritxell Sabidó, Rick Munschauer · 2017 · BMC Neurology
66. A syndemics approach to exercise is medicine
    Caitlin Vitosky Clarke, Brynn Adamson · 2021 · Health An Interdisciplinary Journal for the Social Study of Health Illness and Medicine
67. Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States
    Michele Jara, Thomas Aquilina, Peter M. Aupperle, Adrián L. Rabinowicz · 2015 · Drug Healthcare and Patient Safety
68. DEPRESSION IN MULTIPLE SCLEROSIS – REVIEW
    Smaranda Maier, Rodica Bălașa, Mircea Marian Buruian, Anca Maier, Zoltán Bajkó · 2015 · Romanian Journal of Neurology
69. Cognitive Fatigability is Independent of Subjective Cognitive Fatigue and Mood in Multiple Sclerosis
    Christos Bakirtzis, Ioannis Nikolaidis, Marina Kleopatra Boziki, Artemios Artemiadis, Athina Andravizou, Lambros Messinis, Panagiotis Ioannidis, Nikolaos Grigoriadis · 2020 · Cognitive and Behavioral Neurology
70. Risk assessment of obstructive sleep apnea syndrome and other sleep disorders in multiple sclerosis patients
    Gülin Sunter, Hatice Ömercikoğlu Özden, Ezgi Vural, Dilek İnce Günal, Kadriye Ağan · 2021 · Clinical Neurology and Neurosurgery
71. Influence of Personality, Resilience and Life Conditions on Depression and Anxiety in 104 Patients Having Survived Acute Autoimmune Thrombotic Thrombocytopenic Purpura
    Tanja Falter, Sibylle Böschen, Markus Schepers, Manfred Elmar Beutel, Karl Johannes Lackner, Inge Scharrer, Bernhard Lämmle · 2021 · Journal of Clinical Medicine
72. Quality of life outcomes following surgery for patients with coexistent cervical stenosis and multiple sclerosis
    Daniel Lubelski, Matthew D. Alvin, Michael P. Silverstein, Nilgün Şenol, Kalil G. Abdullah, Edward C. Benzel, Thomas E. Mroz · 2014 · European Spine Journal
73. Cost-effectiveness of nurse-delivered cognitive behavioural therapy (CBT) compared to supportive listening (SL) for adjustment to multiple sclerosis
    Iris Mosweu, Rona E Moss-Morris, L. Dennison, Trudie Chalder, Paul McCrone · 2017 · Health Economics Review
74. Psychopathological dimensions in subjects with hereditary ATTR V30M amyloidosis and their relation with life events due to the disease
    Alice Lopes, Isabel M. Fonseca, Alexandra Sousa, Carla Rodrigues, Margarida Branco, Teresa Coelho, Jorge Sequeiros, Paula Freitas · 2018 · Amyloid
75. Managing symptoms in multiple sclerosis
    Valerie L. Stevenson · 2006 · CRC Press eBooks
76. A group resilience training program for people with multiple sclerosis: Study protocol of a multi-centre cluster-randomized controlled trial (multi-READY for MS)
    Giovannetti, Ambra Mara, Pakenham, Kenneth Ian, Presti, Giovambattista, Quartuccio, Maria Esmeralda, Confalonieri, Paolo, Bergamaschi, Roberto, Grobberio, Monica, Di Filippo, Massimiliano, Micheli, Mary, Brichetto, Giampaolo et al. · 2022 · PLoS ONE
77. Correlation of the symbol digit modalities test with the quality of life and depression in Japanese patients with multiple sclerosis
    Masaaki Niino, Shoko Fukumoto, Tatsusada Okuno, Nobuo Sanjo, Hikoaki Fukaura, Masahiro Mori, Takashi Ohashi, Hideyuki Takeuchi, Yuko Shimizu, Juichi Fujimori et al. · 2021 · Multiple Sclerosis and Related Disorders
78. Affective Disorder and Functional Status as well as Selected Sociodemographic Characteristics in Patients with Multiple Sclerosis, Parkinson’s Disease and History of Stroke
    Andrzej Knapik, Ewa Krzystanek, Justyna Szefler–Derela, Joanna S. Siuda, Jerzy Rottermund, Ryszard Plinta, Anna Brzęk · 2020 · Medicina
79. Why Neurologists Should Remember About Antidepressants
    Maxym Konyushok · 2020 · European Journal of Medical and Health Sciences
80. How I see is how I feel. Identification of illness perception schema and its association with adaptation outcomes in multiple sclerosis – a 5-year prospective study
    Jagoda Różycka · 2021 · PLoS ONE
81. The determinants of depression in a Romanian cohort of multiple sclerosis patients
    Smaranda Maier, Mircea Marian Buruian, Anca Maier, Anca Moțățăianu, Septimiu Toader Voidăzan, Zoltán Bajkó, Rodica Bălașa · 2015 · Acta Neurologica Belgica
82. Bifidobacteria: A probable missing puzzle piece in the pathogenesis of multiple sclerosis
    Mehdi Toghi, Sara Bitarafan, Hosein Delavar Kasmaei, Soudeh Ghafouri‐Fard · 2019 · Multiple Sclerosis and Related Disorders
83. Associated Psychological Disorders and Impairment of Emotional Regulation among Patients with Multiple Sclerosis
    M. T. Andreeva, Татьяна Артуровна Караваева · 2020 · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
84. Effect of Educational Intervention Based on Health-Promoting Self-Care Behaviors Model on Quality of Life, Resilience, and Sense of Coherence in Patients with Multiple Sclerosis: A Randomized Controlled Trial
    Victoria Momenabadi, Mohammad Hossein Kaveh, Nouzar Nakhaee, Kambiz Karimzadeh Shirazi, Maryam Dastoorpoor, Behnaz Sedighi · 2020 · Iranian Red Crescent Medical Journal
85. Clinical effects and tolerability of high-dose, high-frequency recombinant interferon β-1a in patients with multiple sclerosis: maximizing therapy through long-term adherence
    Alexey Boyко · 2010 · Expert Opinion on Biological Therapy
86. Attendance at a psychological support group for people with multiple sclerosis and low mood
    Jessica Holmes, Emma Ford, Faye Yuill, Avril ER Drummond, Nadina Berrice Lincoln · 2011 · Disability and Rehabilitation
87. Psychiatric disorders in neurology.
    Osman Sinanović · 2012 · PubMed
88. The role of psychological well‑being in multiple sclerosis rehabilitation
    Chiara Fanciullacci, Sofía Straudi, Nino Basaglia, Carmelo Chisari · 2017 · European Journal of Physical and Rehabilitation Medicine
89. Social Identity in People with Multiple Sclerosis: An Examination of Family Identity and Mood.
    A. Barker, N. Lincoln, N. Hunt, R. das Nair · 2017 · International Journal of MS Care
90. Anger, Quality of Life and Mood in Multiple Sclerosis
    Christianne M. Laing, Louise H. Phillips · 2015 · Journal of Multiple Sclerosis
91. D-KEFS ST Failure Identifies Multiple Sclerosis Patients With Worse Objective and Self-Perceived Physical and Cognitive Disability
    Alice Riccardi, Marco Puthenparampil, Francesca Rinaldi, Mario Ermani, Paola Perini, Paolo Gallo · 2019 · Frontiers in Psychology
92. Psychological and Neurocognitive Impact of Behcet’s Disease
    Caroline Anne Fisher, Caroline Anne Fisher · 2020 · Neurology and Neurobiology
93. Family Functioning and Multiple Sclerosis: Study Protocol of a Multicentric Italian Project
    Marialaura Di Tella, Virginia Perutelli, Giuseppina Miele, Luigi Lavorgna, Simona Bonavita, Stefania Federica De Mercanti, Lidia Mislin Streito, Marinella Clerico, Lorys Castelli · 2021 · Frontiers in Psychology
94. Predictive Value of the Third Ventricle Width for Neurological Status in Multiple Sclerosis
    Wojciech Guenter, Ewa Betscher, Robert Bonek · 2022 · Journal of Clinical Medicine
95. Linguistic performance during monologues and correlates of neuropsychological function for adults with multiple sclerosis
    Lynda Feenaughty · 2022 · Aphasiology
96. A Comprehensive Evaluation of Multiple Sclerosis–Related Fatigue with a Special Focus on Fatigability
    Nicolas Royer, Callum G. Brownstein, Djahid Kennouche, Loïc Espeit, Anthony Teston, Claire Boutet, Léonard Féasson, Jean‐Philippe Camdessanché, Guillaume Y. Millet · 2023 · Medicine & Science in Sports & Exercise
97. Multiple Sclerosis and Suicide Attempts: A Review including a Meta-Analysis of Prevalence
    Trine Banke d’Andrade, Christina Petrea Larsen, Egon Stenager, Elsebeth Nylev Stenager, Erik Christiansen · 2023 · Acta Neurologica Scandinavica
98. Is Depression Simply a Nonspecific Response to Brain Injury?
    Stephen M. Strakowski, Caleb M. Adler, Melissa P. DelBello · 2013 · Current Psychiatry Reports
99. Maintaining quality of life in multiple sclerosis: fact, fiction, or limited reality?
    Alina Gomide Vasconcelos, Vítor Geraldi Haase, Eduardo de Paula Lima, Marco Aurélio Lana–Peixoto · 2010 · Arquivos de Neuro-Psiquiatria
100. Sclérose en plaques et organisation de la rééducation
     P. Gallien, Benoit Nicolas, A. Guichet · 2009 · EMC - Kinésithérapie - Médecine physique - Réadaptation